Reverse-phase protein lysate microarrays for cell signaling analysis

Nature Protocols

Volumn 3, Issue 11, 2008, Pages 1796-1808

  Spurrier, Brett ^a,b   Ramalingam, Sundhar ^c   Nishizuka, Satoshi ^a,d,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Aushon Biosystems   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d SAIC FREDERICK INC   (United States)

^e IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SIGNAL PEPTIDE;

ARTICLE; CULTURE TECHNIQUE; METABOLISM; METHODOLOGY; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION;

ANTIBODIES; CELL CULTURE TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN ARRAY ANALYSIS; SIGNAL TRANSDUCTION;

EID: 58749095653     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2008.179     Document Type: Article

References (24)

1. Paweletz, C.P.: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981-1989 (2001).
2. Rudelius, M.: Constitutive activation ofAkt contributes to the pathogenesis and survival of mantle cell lymphoma. Btood 108, 1668-1676 (2006).
3. Tibes, R.: Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mot. Cancer Ther. 5, 2512-2521 (2006).
4. Wulfkuhle, J.D.: Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3, 2085-2090 (2003).
5. Ramalingam, S.: Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer Res. 67, 6247-6252 (2007).
6. Nishizuka, S.: Quantitative protein network monitoring in response to DNA damage. J. Proteome Res. 7, 803-808 (2008).
7. Nishizuka, S. and Spurrier, B.: Experimental validation for quantitative protein network models. Curr. Opin. Biotechnot. 19, 41-49 (2008).
8. Utz, P.J.: Protein arrays for studying blood cells and their secreted products. Immunot. Rev. 204, 264-282 (2005).
9. Liotta, L. and Petricoin, E.: Molecular profiling of human cancer. Nat. Rev. Genet.1, 48-56 (2000).
10. Chan, S.M.: Protein microarrays for multiplex analysis ofsignal transduction pathways. Nat. Med. 10, 1390-1396 (2004).
11. Winters, M.E.: Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 65, 3853-3860 (2005).
12. Sevecka, M. and MacBeath, G.: State-based discovery: a multidimensional screen forsmall-molecule modulators of EGF signaling. Nat. Methods 3, 825-831 (2006).
13. Spurrier, B.: Antibody screening database for protein kinetic modeling. Proteomics 7, 3259-3263 (2007).
14. Nishizuka, S.: Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natt Acad. Sci. USA 100, 14229-14234 (2003).
15. Nishizuka, S.: Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 63, 5243-5250 (2003).
16. Sasagawa, S., Ozaki, Y., Fujita, K. and Kuroda, S.: Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cett Biot. 7, 365-373 (2005).
17. Lequin, R.M.: Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Ctin. Chem. 51, 2415-2418 (2005).
18. Anderson, L. and Seilhamer, J.: A comparison of selected mRNA and protein abundances in human liver. Etectrophoresis 18, 533-537 (1997).
19. Nishizuka, S.: Profiling cancer stem cells using protein array technology.Eur. J. Cancer 42, 1273-1282 (2006).
20. Major, S.M.: AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics 7,192 (2006).
21. Nishizuka, S., Washburn, N.R. and Munson, P.J.: Evaluation method of ordinary flatbed scanners for quantitative density analysis. Biotechniques 40, 442-444-446 (2006).
22. Carlisle, A.J.: Development of a prostate cDNA microarray and statistical gene expression analysis package. Mot. Carcinog. 28, 12-22 (2000).
23. Ramaswamy, A.: Application of protein lysate microarrays to molecular marker verification and quantification. Proteome Sci. 3, 9 (2005).
24. Calvert, V.S.: Development of multiplexed protein profiling and detection using near infrared detection of reverse-phase protein microarrays. Ctin. Proteomics J. 1, 81-89 (2004).